MedPath

Evaluation of the levels of immune response in teeth that have undergone cell death after placing simvastatin as an root canal medicine.

Phase 4
Completed
Conditions
Necrosis of pulp,
Registration Number
CTRI/2022/08/044749
Lead Sponsor
SRM Dental College
Brief Summary

This study is a triple-blinded randomized controlled clinical trial aimed to compare and evaluate the levels of interleukin-6 in teeth with pulp necrosis and symptomatic apical periodontitis following placement of simvastatin as an intracanal medicament conducted in Chennai, India with the primary outcome measure being a 10% increased efficacy of simvastatin in reduction of Interleukin -6 levels compared to calcium hydroxide after a period of 7 days.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
34
Inclusion Criteria

ASA score 1 Healthy patients aged 16-60 years patients diagnosed with pulpal necrosis and symptomatic apical periodontitis (PAI ≤2) Single rooted teeth with single canal and closed apex.

Exclusion Criteria
  • Patients under ASA 2-5 category.
  • Patients under any medication for a week.
  • Patients with periapical pathology (PAI score >2) Teeth with cracks, vertical root fracture, internal & external resorption.
  • Multirooted teeth, Single rooted teeth with multiple canals.
  • Teeth with immature apex.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quantification and comparison ofSamples will be taken before and after biomechanics preparation and after 7 days of intracanal medication placement.
placement of simvastatin will showSamples will be taken before and after biomechanics preparation and after 7 days of intracanal medication placement.
Interleukin-6 before and afterSamples will be taken before and after biomechanics preparation and after 7 days of intracanal medication placement.
decrease in its concentrationSamples will be taken before and after biomechanics preparation and after 7 days of intracanal medication placement.
Secondary Outcome Measures
NameTimeMethod
Quantification and comparison ofInterleukin-6 before and after

Trial Locations

Locations (1)

SRM Dental College

🇮🇳

Chennai, TAMIL NADU, India

SRM Dental College
🇮🇳Chennai, TAMIL NADU, India
Dr Nikhil Harikrishnan
Principal investigator
9400430067
nikhilmeloth@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.